Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IGRT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02772588
What this trial is testing

AASUR in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 64
Not applicableStudy completedNCT05785845
What this trial is testing

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Early Stage Non-small Cell Lung CancerNon-small Cell Lung Cancer
Washington University School of Medicine 17
Not applicableStudy completedNCT03623334
What this trial is testing

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 55
Not applicableStudy completedNCT02761889
What this trial is testing

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Fundacao Champalimaud 444
Testing effectiveness (Phase 2)Study completedNCT00809991
What this trial is testing

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 91
Not applicableEnded earlyNCT02279693
What this trial is testing

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 3
Not applicableLooking for participantsNCT06681233
What this trial is testing

Feasibility Study of CBCT for IGRT in Cancer Patients

Who this might be right for
Head and Neck CancersBreast CancerThoracic Cancers+3 more
Varian, a Siemens Healthineers Company 50
Not applicableStudy completedNCT03030625
What this trial is testing

VMAT for Dominant Intraprostatic Lesion

Who this might be right for
Prostate Cancer
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 30
Early research (Phase 1)WithdrawnNCT01514955
What this trial is testing

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer

Who this might be right for
Integrated MRI Based RT as Standard of CareLocally Advanced Cervical Cancer
AHS Cancer Control Alberta
Not applicableLooking for participantsNCT06230549
What this trial is testing

Adaptive Radiotherapy in Patients With Gynecological Tumors

Who this might be right for
Gynecological TumorAdaptive RadiotherapyRadiation+5 more
University Hospital, Essen 30
Not applicableActive Not RecruitingNCT01742403
What this trial is testing

Continuous Monitoring of Prostate Position During Radiotherapy

Who this might be right for
Prostate Cancer
Royal North Shore Hospital 100
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Not applicableLooking for participantsNCT04035642
What this trial is testing

Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)

Who this might be right for
Prostate Cancer
Fundacao Champalimaud 200
Not applicableStudy completedNCT05746156
What this trial is testing

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

Who this might be right for
Locally Advanced Cervical Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 17
Not applicableLooking for participantsNCT07463833
What this trial is testing

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

Who this might be right for
CancerProstate Cancer
UNC Lineberger Comprehensive Cancer Center 207
Not applicableNot Yet RecruitingNCT06708221
What this trial is testing

A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods

Who this might be right for
Cancer
University of Sydney 40
Large-scale testing (Phase 3)Looking for participantsNCT06825091
What this trial is testing

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

Who this might be right for
Localized Prostate CancerStereotactic Body Radiotherapy
University Health Network, Toronto 320
Early research (Phase 1)WithdrawnNCT01163448
What this trial is testing

Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00963404
What this trial is testing

Image-Guided Tumorboost of Bladder Cancer

Who this might be right for
Bladder Neoplasms
University of Aarhus 19
Not applicableUnknownNCT04538547
What this trial is testing

Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx

Who this might be right for
Carcinoma, Nasopharyngeal
Post Graduate Institute of Medical Education and Research, Chandigarh 120
Next Page